Nasdaq Gives TNL Mediagene One More Shot, as $1 Bid Rule and Equity Test Loom
TNL Mediagene (NASDAQ:TNMG) has won a reprieve from Nasdaq, but investors should not mistake the decision for a clean bill of health. The Nasdaq Hearings Panel has granted the Tokyo-based digital media and technology company continued listing on the Nasdaq Capital Market, subject to two hard deadlines that could determine whether TNMG remains a Nasdaq-listed stock.